Human scleral hydraulic conductivity: Age-related changes, topographical variation, and potential scleral outflow facility

被引:36
作者
Jackson, Timothy L.
Hussain, Ali
Hodgetts, Andrea
Morley, Ana M. S.
Hillenkamp, Jost
Sullivan, Paul M.
Marshall, John
机构
[1] Moorfields Eye Hosp, Vitreoretinal Unit, London EC1V 2PD, England
[2] GKT Med Sch, Rayne Inst, Acad Dept Ophthalmol, London, England
[3] Univ Regensburg, Eye Clin, D-8400 Regensburg, Germany
关键词
D O I
10.1167/iovs.06-0362
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To measure the specific hydraulic conductivity (K) of human sclera over a range of ages, to assess topographical variation, and to provide a theoretical estimate of potential scleral outflow facility. METHODS. Human donor sclera (n = 18; mean age 56.7 +/- 25.9 years; range 4-89) was clamped in a modified Ussing chamber connected to a water column set at 15.7 mm Hg. Column descent was measured over 24 hours at 20 degrees C with a digital micrometer. Scleral thickness of glutaraldehyde-fixed specimens was measured by light microscopy, taking the mean of 15 measurements per donor. Topographical variation in hydraulic conductivity (HC) was determined in an additional 10 donor eyes (mean age, 54.1 +/- 26.4 years; range 12-89), comparing anterior, equatorial, and posterior sclera. The potential transscleral outflow facility was calculated by multiplying HC by total scleral surface area and adjusting water viscosity to core body temperature. RESULTS. Mean K +/- 1SD in adults (> 18 years) was 5.85 +/- 3.89 x 10(-18) m(2). K tended to be higher in pediatric donors, but there was no statistically significant age-related change. However, when all data sets were combined (n = 28), HC showed a significant decline with age. There was no significant topographical variation in HC. The potential transscleral outflow facility was 0.33 mu L (.) min(-1) (.) mm Hg-1. CONCLUSIONS. Quantifying HC may help refine ocular pharmacotherapy, as transscleral water movement increases intraocular drug elimination and impedes transscleral drug delivery. The potential scleral outflow is two to three times higher than that which occurs in vivo; hence, medical or surgical interventions that fully exploit this pathway have considerable capacity to lower intraocular pressure.
引用
收藏
页码:4942 / 4946
页数:5
相关论文
共 39 条
[1]   Transscleral-RPE permeability of PEDF and ovalbumin proteins: Implications for subconjunctival protein delivery [J].
Amaral, J ;
Fariss, RN ;
Campos, MM ;
Robison, WG ;
Kim, H ;
Lutz, R ;
Becerra, SP .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (12) :4383-4392
[2]  
Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
[3]  
Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1186
[4]  
Antcliff RJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P539
[5]  
BILL ANDERS, 1966, INVEST OPHTHALMOL, V5, P170
[6]   Differential effects of aging on transport properties of anterior and posterior human sclera [J].
Boubriak, OA ;
Urban, JPG ;
Bron, AJ .
EXPERIMENTAL EYE RESEARCH, 2003, 76 (06) :701-713
[7]   The effect of hydration and matrix composition on solute diffusion in rabbit sclera [J].
Boubriak, OA ;
Urban, JPG ;
Akhtar, S ;
Meek, KM ;
Bron, AJ .
EXPERIMENTAL EYE RESEARCH, 2000, 71 (05) :503-514
[8]   AGE-RELATED-CHANGES OF SCLERAL HYDRATION AND SULFATED GLYCOSAMINOGLYCANS [J].
BROWN, CT ;
VURAL, M ;
JOHNSON, M ;
TRINKAUSRANDALL, V .
MECHANISMS OF AGEING AND DEVELOPMENT, 1994, 77 (02) :97-107
[9]   Effective transscleral delivery of two retinal anti-angiogenic molecules -: Carboxyamido-triazole (CAI) and 2-methoxyestradiol (2ME2) [J].
Cruysberg, LPJ ;
Franklin, AJ ;
Sanders, J ;
Self, C ;
Yuan, P ;
Csaky, KG ;
Robinson, MR ;
Kohn, EC ;
Edelhauser, HF .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (08) :1022-1031
[10]   In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant [J].
Cruysberg, LPJ ;
Nuijts, RMMA ;
Gilbert, JA ;
Geroski, DH ;
Hendrikse, F ;
Edelhauser, HF .
CURRENT EYE RESEARCH, 2005, 30 (08) :653-660